Literature DB >> 9325099

The high resolution crystal structure of deoxyhemoglobin S.

D J Harrington1, K Adachi, W E Royer.   

Abstract

We have refined the crystal structure of deoxyhemoglobin S (beta Glu6-->Val) at 2.05 A resolution to an R-factor of 16.5% (free R=21. 5%) using crystals isomorphous to those originally grown by Wishner and Love. A predominant feature of this crystal form is a double strand of hemoglobin tetramers that has been shown by a variety of techniques to be the fundamental building block of the intracellular sickle cell fiber. The double strand is stabilized by lateral contacts involving the mutant valine interacting with a pocket between the E and F helices on another tetramer. The new structure reveals some marked differences from the previously refined 3.0 A resolution structure, including several residues in the lateral contact which have shifted by as much as 3.5 A. The lateral contact includes, in addition to the hydrophobic interactions involving the mutant valine, hydrophilic interactions and bridging water molecules at the periphery of the contact. This structure provides further insights into hemoglobin polymerization and may be useful for the structure-based design of therapeutic agents to treat sickle cell disease. Copyright 1997 Academic Press Limited.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9325099     DOI: 10.1006/jmbi.1997.1253

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  42 in total

1.  A model for the sickle hemoglobin fiber using both mutation sites.

Authors:  A Roufberg; F A Ferrone
Journal:  Protein Sci       Date:  2000-05       Impact factor: 6.725

2.  Heterogeneous nucleation and crowding in sickle hemoglobin: an analytic approach.

Authors:  Frank A Ferrone; Maria Ivanova; Ravi Jasuja
Journal:  Biophys J       Date:  2002-01       Impact factor: 4.033

3.  Heterogeneous nucleation in sickle hemoglobin: experimental validation of a structural mechanism.

Authors:  Maria A Rotter; Suzanna Kwong; Robin W Briehl; Frank A Ferrone
Journal:  Biophys J       Date:  2005-07-29       Impact factor: 4.033

4.  Insights into the pathogenesis of dominant retinitis pigmentosa associated with a D477G mutation in RPE65.

Authors:  Elliot H Choi; Susie Suh; Christopher L Sander; Christian J Ortiz Hernandez; Elizabeth R Bulman; Nimesh Khadka; Zhiqian Dong; Wuxian Shi; Krzysztof Palczewski; Philip D Kiser
Journal:  Hum Mol Genet       Date:  2018-07-01       Impact factor: 6.150

5.  Molecular insights into the irreversible mechanical behavior of sickle hemoglobin.

Authors:  Sumith Yesudasan; Simone A Douglas; Manu O Platt; Xianqiao Wang; Rodney D Averett
Journal:  J Biomol Struct Dyn       Date:  2018-05-04

6.  Design of therapeutic proteins with enhanced stability.

Authors:  Naresh Chennamsetty; Vladimir Voynov; Veysel Kayser; Bernhard Helk; Bernhardt L Trout
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-01       Impact factor: 11.205

7.  Solubility of fluoromethemoglobin S: effect of phosphate and temperature on polymerization.

Authors:  M E Yohe; K M Sheffield; I Mukerji
Journal:  Biophys J       Date:  2000-06       Impact factor: 4.033

8.  Inhibition of hemoglobin S polymerization in vitro by a novel 15-mer EF-helix beta73 histidine-containing peptide.

Authors:  Mohammed G K Akbar; Yutaka Tamura; Min Ding; Hua Ding; Michael M Rosenblatt; Konda S Reddy; Saul Surrey; Kazuhiko Adachi
Journal:  Biochemistry       Date:  2006-07-11       Impact factor: 3.162

9.  Structures and oxygen affinities of crystalline human hemoglobin C (β6 Glu->Lys) in the R and R2 quaternary structures.

Authors:  Naoya Shibayama; Kanako Sugiyama; Sam-Yong Park
Journal:  J Biol Chem       Date:  2011-08-04       Impact factor: 5.157

10.  A human embryonic hemoglobin inhibits Hb S polymerization in vitro and restores a normal phenotype to mouse models of sickle cell disease.

Authors:  Zhenning He; J Eric Russell
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.